RN
Rajeev Naithani
About Rajeev Naithani
Rajeev Naithani has 6 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Noshi India Pharmaceuticals Private Limited and Clini-Ton Biologics Private Limited. Formerly with 1 company, such as Vanmed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Noshi India Pharmaceuticals Private Limited
U33112DL2022PTC402815
|
Director | 04 Aug 2022 | 2022 | Active |
Clini-Ton Biologics Private Limited
U51397RJ2021PTC076965
|
Director | 08 Sep 2025 | 2021 | Active |
Yomed Clinical Solutions Private Limited
U72200RJ2024PTC094326
|
Additional Director | 01 Aug 2025 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Vanmed Pharmaceuticals Private Limited
U24100UP2016PTC231729
|
Director | 08 Jul 2020 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Naithani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Naithani
Rajeev Naithani has 6 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Noshi India Pharmaceuticals Private Limited and Clini-Ton Biologics Private Limited. Formerly with 1 company, such as Vanmed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Rajeev Naithani is associated with 3 companies as Director and Additional Director.
Rajeev Naithani has expertise in General Business.
Rajeev Naithani has 6 years in corporate governance.